Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation.
about
Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunctionOptimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal DiseasesFcgamma receptors: structure, function and role as genetic risk factors in SLEInfections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation.Large-scale ex vivo generation of human neutrophils from cord blood CD34+ cells.A critical concentration of neutrophils is required for effective bacterial killing in suspension.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Pretreatment with phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor SF1670 augments the efficacy of granulocyte transfusion in a clinically relevant mouse modelPulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience.Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia.Gravity sedimentation of granulocytapheresis concentrates with hydroxyethyl starch efficiently removes red blood cells and retains neutrophils.The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohortTen-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone.Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversiesPolycythemia in an infant secondary to granulocyte transfusions.Serial granulocyte transfusions as a treatment for sepsis due to multidrug-resistant Pseudomonas aeruginosa in a neutropenic patient.Efficacy and side effects of granulocyte collection in healthy donors.Granulocyte transfusions in severe aplastic anemia: an eleven-year experience.Concise review: next-generation cell therapies to prevent infections in neutropenic patients.Experimental evidence that granulocyte transfusions are efficacious in treatment of neutropenic hosts with pulmonary aspergillosis.Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection.Oral neutrophils are an independent marker of the systemic inflammatory response after cardiac bypass.Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis.Hematopoietic stem cell transplantation in a very high risk group of patients with the support of granulocyte transfusion.Granulocyte transfusion therapy: randomization after all?Recent Advances in the Treatment of Scedosporiosis and Fusariosis.
P2860
Q24186972-4FBC267F-CE7A-45F3-95ED-C841417EDE87Q26774692-F53C3533-1748-4ACC-8D02-33A09E3D87EEQ33697484-A4A6813C-B5CB-4572-B93A-1178CD35E1B7Q33892585-4441E0DF-9C47-4AAC-BF53-55BF49472B55Q33898287-64E89482-843E-4B4B-8F05-7E61B113B132Q34032375-C077BB6A-3031-46A8-A722-807EE2C69EF8Q34505582-4277A583-0973-433C-BA32-C9B4D9113614Q34532546-875C4307-7B07-4636-AE50-9BFBC5B532C5Q35067637-B5A803C6-1944-4D07-8614-31F8DAD805FCQ35889014-66F16A73-0FAA-4786-B5EE-EB690A0B94F6Q36068691-66DA99E0-32A7-485A-A24F-986DCEE1030CQ36093849-B9BD9354-FE49-4877-85E5-A9218E0C8CD2Q36170080-9ED29FAD-3421-4702-8503-E1B719C131E6Q36170101-C7A3A684-0166-41A3-A413-01207345A447Q36180365-214E5915-91F8-42C6-8129-DE3D9532F666Q36225173-342EC1ED-FEAE-4BE6-8EDA-B05904E81EE5Q36286585-05637704-B614-4A3E-B167-309D7D48E74FQ36599557-8970E5DF-698C-4814-A6B5-34AF9418C2FDQ36892237-4ADE7B70-CC9D-4B82-A06F-5F37717161EBQ37180865-866402EE-9A1A-4B95-B8FA-80CCCFCC2F0EQ37470931-265E42CC-79C8-4A1F-BEE4-16E3A7F7AD22Q38193653-57181C5A-B516-42A9-862B-69D87FC35381Q39765887-8FD4C759-A662-4520-9DB4-39FE5A3AFBA6Q40099377-4CB3DE7D-767C-479A-B66C-DA3A0017572CQ41686993-EBC871C9-EC14-4F3C-BC31-560FAE724E77Q42112304-780040D8-DDB8-40C6-82BD-0F427FA6AC02Q42867046-D5FA56C1-EA03-404B-AE8C-E88F5B4F91BDQ42956275-1CD515F1-832E-4658-B21F-1911F5A8F6F3Q55453637-504B9798-05CD-4725-8C61-68CF15E45F1F
P2860
Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Phase I/II trial of neutrophil ...... tic stem cell transplantation.
@en
type
label
Phase I/II trial of neutrophil ...... tic stem cell transplantation.
@en
prefLabel
Phase I/II trial of neutrophil ...... tic stem cell transplantation.
@en
P2093
P921
P1433
P1476
Phase I/II trial of neutrophil ...... etic stem cell transplantation
@en
P2093
P304
P407
P577
2000-06-01T00:00:00Z